Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
Peroxisome proliferator-activated receptor β/δ (PPARβ/δ), the most PPAR abundant isotype in the central nervous system, is involved in microglial homeostasis and metabolism, whose disturbances have been demonstrated to play a key role in memory impairment. Although PPARβ/δ function is well-establish...
Main Authors: | Triana Espinosa-Jiménez, Oriol Busquets, Amanda Cano, Elena Sánchez-López, Ester Verdaguer, Antoni Parcerisas, Jordi Olloquequi, Carme Auladell, Jaume Folch, Walter Wahli, Manuel Vázquez-Carrera, Antoni Camins, Miren Ettcheto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.902047/full |
Similar Items
-
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
by: Triana Espinosa-Jiménez, et al.
Published: (2023-03-01) -
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
by: Jordi Olloquequi, et al.
Published: (2022-11-01) -
Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
by: Jordi Olloquequi, et al.
Published: (2023-09-01) -
Involvement of JNK1 in Neuronal Polarization During Brain Development
by: Rubén Darío Castro-Torres, et al.
Published: (2020-08-01) -
LICOCHALCONE A AS A POTENTIAL MULTI-TARGET DRUG AGAINST COGNITIVE DYSFUNCTION IN LPS-INDUCED NEUROINFLAMMATION MICE MODEL
by: Marina Carrasco, et al.
Published: (2023-10-01)